Last 12 months
Inside the activity.
5 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 4 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 17, 2025 Filed Aug 19, 2025 20:06 UTC |
Finney KevinDirector
|
PurchaseCommon Stock | 794 | $0.38 | $301.72 |
DisclosureSEC source: 0001437749-25-027356 · rdgdoc.xml · nonDerivative · entry 1 Finney Kevin · CIK 0002053381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,897 F1 · date: This transaction is being reported late due to an administrative oversight. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 01:06 UTC |
Finney KevinDirector
|
GrantStock Option (right to buy) · Derivative | 36,392 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001437749-25-020572 · rdgdoc.xml · derivative · entry 2 Finney Kevin · CIK 0002053381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,392 Underlying: Common Stock · 36,392 shares Expires 2035-06-13 F2 · derivative.exercise_date: The shares subject to this option shall vest on the earlier of the date immediately prior of the 2026 annual meeting of stockholders of the Issuer and June 13, 2026, the first anniversary of the date of the grant. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 01:06 UTC |
Finney KevinDirector
|
GrantCommon Stock | 6,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-020572 · rdgdoc.xml · nonDerivative · entry 1 Finney Kevin · CIK 0002053381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,103 F1 · shares: Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2026 annual meeting of stockholders of the Issuer and June 13, 2026, the first anniversary date of the grant. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 01:05 UTC |
Watson W. MarkDirector
|
GrantStock Option (right to buy) · Derivative | 95,400 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001437749-25-020571 · rdgdoc.xml · derivative · entry 2 Watson W. Mark · CIK 0001612372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,400 Underlying: Common Stock · 95,400 shares Expires 2035-06-13 F2 · derivative.exercise_date: The shares subject to this option shall vest on the earlier of the date immediately prior of the 2026 annual meeting of stockholders of the Issuer and June 13, 2026, the first anniversary of the date of the grant. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 01:05 UTC |
Watson W. MarkDirector
|
GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-020571 · rdgdoc.xml · nonDerivative · entry 1 Watson W. Mark · CIK 0001612372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,125 F1 · shares: Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2026 annual meeting of stockholders of the Issuer and June 13, 2026, the first anniversary date of the grant. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 01:04 UTC |
HERON ELAINE JDirector
|
GrantStock Option (right to buy) · Derivative | 95,400 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001437749-25-020570 · rdgdoc.xml · derivative · entry 2 HERON ELAINE J · CIK 0001235471 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,400 Underlying: Common Stock · 95,400 shares Expires 2035-06-13 F2 · derivative.exercise_date: The shares subject to this option shall vest on the earlier of the date immediately prior of the 2026 annual meeting of stockholders of the Issuer and June 13, 2026, the first anniversary of the date of the grant. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 01:04 UTC |
HERON ELAINE JDirector
|
GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-020570 · rdgdoc.xml · nonDerivative · entry 1 HERON ELAINE J · CIK 0001235471 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,566 F1 · shares: Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2026 annual meeting of stockholders of the Issuer and June 13, 2026, the first anniversary date of the grant. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 01:03 UTC |
Wheadon David E.Director
|
GrantStock Option (right to buy) · Derivative | 95,400 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001437749-25-020569 · rdgdoc.xml · derivative · entry 2 Wheadon David E. · CIK 0001789507 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,400 Underlying: Common Stock · 95,400 shares Expires 2035-06-13 F2 · derivative.exercise_date: The shares subject to this option shall vest on the earlier of the date immediately prior of the 2026 annual meeting of stockholders of the Issuer and June 13, 2026, the first anniversary of the date of the grant. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 01:03 UTC |
Wheadon David E.Director
|
GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-020569 · rdgdoc.xml · nonDerivative · entry 1 Wheadon David E. · CIK 0001789507 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,750 F1 · shares: Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2026 annual meeting of stockholders of the Issuer and June 13, 2026, the first anniversary date of the grant. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 01:02 UTC |
Finney Michael J.Director
|
GrantStock Option (right to buy) · Derivative | 95,400 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001437749-25-020568 · rdgdoc.xml · derivative · entry 2 Finney Michael J. · CIK 0001650978 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,400 Underlying: Common Stock · 95,400 shares Expires 2035-06-13 F2 · derivative.exercise_date: The shares subject to this option shall vest on the earlier of the date immediately prior of the 2026 annual meeting of stockholders of the Issuer and June 13, 2026, the first anniversary of the date of the grant. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 01:02 UTC |
Finney Michael J.Director
|
GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-020568 · rdgdoc.xml · nonDerivative · entry 1 Finney Michael J. · CIK 0001650978 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 702,840 F1 · shares: Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2026 annual meeting of stockholders of the Issuer and June 13, 2026, the first anniversary date of the grant. Read SEC document |
| May 19, 2025 Filed May 19, 2025 22:49 UTC |
Lo StevenDirector · President, Chief Exec Officer
|
PurchaseCommon Stock | 100,000 | $0.49 | $49,000.00 |
DisclosureSEC source: 0001437749-25-017678 · rdgdoc.xml · nonDerivative · entry 1 Lo Steven · CIK 0001501959 · Director · President, Chief Exec Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By The Lo Family Trust Disclosed balance after: 100,000 F1 · ownership.nature: Represents 100,000 shares held by The Lo Family Trust, of which Mr. Lo is a trustee and a beneficiary. Read SEC document |
| May 19, 2025 Filed May 20, 2025 14:45 UTC |
Grasman Jeroen NicolaasChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 1,000,000 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0001437749-25-017732 · rdgdoc.xml · derivative · entry 2 Grasman Jeroen Nicolaas · CIK 0002067766 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2035-05-19 F2 · derivative.exercise_date: The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on May 19, 2026, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on May 19, 2029. Read SEC document |
| May 19, 2025 Filed May 20, 2025 14:45 UTC |
Grasman Jeroen NicolaasChief Financial Officer
|
GrantCommon Stock | 350,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-017732 · rdgdoc.xml · nonDerivative · entry 1 Grasman Jeroen Nicolaas · CIK 0002067766 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,000 F1 · shares: Grant of shares upon vesting of restricted stock units. Twenty five percent of the shares underlying the award shall vest on each anniversary of the vesting commencement date of May 19, 2025, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date. Read SEC document |
| March 28, 2025 Filed Apr 1, 2025 22:46 UTC |
Cummings James F.Chief Medical Officer
|
Tax withholdingCommon Stock | 3,292 | $0.42 | $1,386.59 |
DisclosureSEC source: 0001437749-25-010519 · rdgdoc.xml · nonDerivative · entry 1 Cummings James F. · CIK 0001886760 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 745,757 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of March 28, 2025. Read SEC document |
| March 28, 2025 Filed Apr 1, 2025 20:53 UTC |
Tucker SeanSVP, Chief Scientific Officer
|
Tax withholdingCommon Stock | 3,913 | $0.42 | $1,648.16 |
DisclosureSEC source: 0001437749-25-010486 · rdgdoc.xml · nonDerivative · entry 1 Tucker Sean · CIK 0001652204 · SVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 740,490 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of March 28, 2025. Read SEC document |
| March 24, 2025 Filed Mar 27, 2025 01:54 UTC |
Lo StevenDirector · President, Chief Exec Officer
|
GrantStock Option (right to buy) · Derivative | 2,108,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001437749-25-009452 · rdgdoc.xml · derivative · entry 2 Lo Steven · CIK 0001501959 · Director · President, Chief Exec Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,108,000 Underlying: Common Stock · 2,108,000 shares Expires 2035-03-24 F2 · derivative.exercise_date: The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 24, 2026, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 24, 2029. Read SEC document |
| March 24, 2025 Filed Mar 27, 2025 01:54 UTC |
Lo StevenDirector · President, Chief Exec Officer
|
GrantCommon Stock | 1,405,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-009452 · rdgdoc.xml · nonDerivative · entry 1 Lo Steven · CIK 0001501959 · Director · President, Chief Exec Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,632,638 F1 · shares: Grant of shares upon vesting of restricted stock units. 25% of the shares underlying the award shall vest on each anniversary of the vesting commencement date of March 24, 2025, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date. Read SEC document |
| March 24, 2025 Filed Mar 27, 2025 01:53 UTC |
Tucker SeanSVP, Chief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 610,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001437749-25-009451 · rdgdoc.xml · derivative · entry 4 Tucker Sean · CIK 0001652204 · SVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 610,000 Underlying: Common Stock · 610,000 shares Expires 2035-03-24 F2 · derivative.exercise_date: The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 24, 2026, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 24, 2029. Read SEC document |
| March 24, 2025 Filed Mar 27, 2025 01:53 UTC |
Tucker SeanSVP, Chief Scientific Officer
|
GrantCommon Stock | 406,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-009451 · rdgdoc.xml · nonDerivative · entry 1 Tucker Sean · CIK 0001652204 · SVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 744,403 F1 · shares: Grant of shares upon vesting of restricted stock units. 25% of the shares underlying the award shall vest on each anniversary of the vesting commencement date of March 24, 2025, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date. Read SEC document |
| March 24, 2025 Filed Mar 27, 2025 01:53 UTC |
Lee Phillip EChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 610,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001437749-25-009449 · rdgdoc.xml · derivative · entry 2 Lee Phillip E · CIK 0001959565 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 610,000 Underlying: Common Stock · 610,000 shares Expires 2035-03-24 F2 · derivative.exercise_date: The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 24, 2026, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 24, 2029. Read SEC document |
| March 24, 2025 Filed Mar 27, 2025 01:53 UTC |
Lee Phillip EChief Financial Officer
|
GrantCommon Stock | 406,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-009449 · rdgdoc.xml · nonDerivative · entry 1 Lee Phillip E · CIK 0001959565 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 631,619 F1 · shares: Grant of shares upon vesting of restricted stock units. 25% of the shares underlying the award shall vest on each anniversary of the vesting commencement date of March 24, 2025, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date. Read SEC document |
| March 24, 2025 Filed Mar 27, 2025 01:52 UTC |
Cummings James F.Chief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001437749-25-009448 · rdgdoc.xml · derivative · entry 3 Cummings James F. · CIK 0001886760 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-03-24 F2 · derivative.exercise_date: The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 24, 2026, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 24, 2029. Read SEC document |
| March 24, 2025 Filed Mar 27, 2025 01:52 UTC |
Cummings James F.Chief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 610,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001437749-25-009448 · rdgdoc.xml · derivative · entry 2 Cummings James F. · CIK 0001886760 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 610,000 Underlying: Common Stock · 610,000 shares Expires 2035-03-24 F2 · derivative.exercise_date: The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 24, 2026, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 24, 2029. Read SEC document |
| March 24, 2025 Filed Mar 27, 2025 01:52 UTC |
Cummings James F.Chief Medical Officer
|
GrantCommon Stock | 406,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-009448 · rdgdoc.xml · nonDerivative · entry 1 Cummings James F. · CIK 0001886760 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 749,049 F1 · shares: Grant of shares upon vesting of restricted stock units. 25% of the shares underlying the award shall vest on each anniversary of the vesting commencement date of March 24, 2025, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date. Read SEC document |
| March 24, 2025 Filed Mar 27, 2025 01:51 UTC |
Berg Edward BSVP, General Counsel
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001437749-25-009446 · rdgdoc.xml · derivative · entry 3 Berg Edward B · CIK 0001912178 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-03-24 F2 · derivative.exercise_date: The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 24, 2026, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 24, 2029. Read SEC document |
| March 24, 2025 Filed Mar 27, 2025 01:51 UTC |
Berg Edward BSVP, General Counsel
|
GrantStock Option (right to buy) · Derivative | 610,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001437749-25-009446 · rdgdoc.xml · derivative · entry 2 Berg Edward B · CIK 0001912178 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 610,000 Underlying: Common Stock · 610,000 shares Expires 2035-03-24 F2 · derivative.exercise_date: The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 24, 2026, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 24, 2029. Read SEC document |
| March 24, 2025 Filed Mar 27, 2025 01:51 UTC |
Berg Edward BSVP, General Counsel
|
GrantCommon Stock | 406,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-009446 · rdgdoc.xml · nonDerivative · entry 1 Berg Edward B · CIK 0001912178 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 694,123 F1 · shares: Grant of shares upon vesting of restricted stock units. 25% of the shares underlying the award shall vest on each anniversary of the vesting commencement date of March 24, 2025, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date. Read SEC document |
| March 18, 2025 Filed Mar 21, 2025 01:44 UTC |
Berg Edward BSVP, General Counsel
|
Tax withholdingCommon Stock | 8,050 | $0.57 | $4,590.11 |
DisclosureSEC source: 0001437749-25-008654 · rdgdoc.xml · nonDerivative · entry 1 Berg Edward B · CIK 0001912178 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 288,123 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of March 18, 2025. F2 · balance_after: Includes 70,781 shares acquired under the Vaxart, Inc. 2022 Employee Stock Purchase Plan. Read SEC document |
| March 18, 2025 Filed Mar 21, 2025 01:43 UTC |
Cummings James F.Chief Medical Officer
|
Tax withholdingCommon Stock | 6,772 | $0.57 | $3,861.39 |
DisclosureSEC source: 0001437749-25-008653 · rdgdoc.xml · nonDerivative · entry 2 Cummings James F. · CIK 0001886760 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 343,049 F3 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of March 18, 2025. F4 · balance_after: Includes 75,618 shares acquired under the Vaxart, Inc. 2022 Employee Stock Purchase Plan. Read SEC document |
| March 18, 2025 Filed Mar 21, 2025 01:28 UTC |
Lo StevenDirector · President, Chief Exec Officer
|
Tax withholdingCommon Stock | 22,362 | $0.57 | $12,750.81 |
DisclosureSEC source: 0001437749-25-008651 · rdgdoc.xml · nonDerivative · entry 1 Lo Steven · CIK 0001501959 · Director · President, Chief Exec Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 227,638 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of March 18, 2025. Read SEC document |
| March 18, 2025 Filed Mar 21, 2025 01:27 UTC |
Tucker SeanSVP, Chief Scientific Officer
|
Tax withholdingCommon Stock | 8,050 | $0.57 | $4,590.11 |
DisclosureSEC source: 0001437749-25-008650 · rdgdoc.xml · nonDerivative · entry 1 Tucker Sean · CIK 0001652204 · SVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338,403 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of March 18, 2025. Read SEC document |
| March 18, 2025 Filed Mar 21, 2025 01:26 UTC |
Lee Phillip EChief Financial Officer
|
Tax withholdingCommon Stock | 8,050 | $0.57 | $4,590.11 |
DisclosureSEC source: 0001437749-25-008649 · rdgdoc.xml · nonDerivative · entry 1 Lee Phillip E · CIK 0001959565 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,619 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of March 18, 2025. Read SEC document |
| February 02, 2025 Filed Feb 5, 2025 01:11 UTC |
Tucker SeanSVP, Chief Scientific Officer
|
Tax withholdingCommon Stock | 9,242 | $0.68 | $6,282.71 |
DisclosureSEC source: 0001437749-25-002803 · rdgdoc.xml · nonDerivative · entry 1 Tucker Sean · CIK 0001652204 · SVP, Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 346,453 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of February 2, 2025. Read SEC document |
| February 02, 2025 Filed Feb 5, 2025 01:11 UTC |
Cummings James F.Chief Medical Officer
|
Tax withholdingCommon Stock | 7,964 | $0.68 | $5,413.93 |
DisclosureSEC source: 0001437749-25-002802 · rdgdoc.xml · nonDerivative · entry 1 Cummings James F. · CIK 0001886760 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 318,837 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of February 2, 2025. Read SEC document |
| February 02, 2025 Filed Feb 5, 2025 01:10 UTC |
Berg Edward BSVP, General Counsel
|
Tax withholdingCommon Stock | 9,242 | $0.68 | $6,282.71 |
DisclosureSEC source: 0001437749-25-002801 · rdgdoc.xml · nonDerivative · entry 1 Berg Edward B · CIK 0001912178 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 261,464 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of February 2, 2025. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 01:05 UTC |
Finney KevinDirector
|
GrantStock Option (right to buy) · Derivative | 190,800 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001437749-25-002175 · rdgdoc.xml · derivative · entry 2 Finney Kevin · CIK 0002053381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,800 Underlying: Common Stock · 190,800 shares Expires 2035-01-28 F2 · derivative.exercise_date: The shares subject to this option shall vest annually over three years from the vesting commencement date of January 28, 2025, the date of the grantee's appointment as a director of Vaxart, Inc. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 01:05 UTC |
Finney KevinDirector
|
GrantCommon Stock | 32,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-002175 · rdgdoc.xml · nonDerivative · entry 1 Finney Kevin · CIK 0002053381 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,000 F1 · shares: Grant of shares upon vesting of restricted stock units. One third of the shares underlying the award shall vest on each anniversary of the grant date, so that the restricted stock units would be fully vested on the third anniversary of the grant date. Read SEC document |
| December 15, 2024 Filed Dec 17, 2024 21:52 UTC |
Lee Phillip EChief Financial Officer
|
Tax withholdingCommon Stock | 6,132 | $0.59 | $3,630.14 |
DisclosureSEC source: 0001437749-24-037740 · rdgdoc.xml · nonDerivative · entry 1 Lee Phillip E · CIK 0001959565 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 233,669 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of December 15, 2024. Read SEC document |
| June 18, 2024 Filed Jun 20, 2024 10:10 UTC |
Watson W. MarkDirector
|
PurchaseCommon Stock | 20,000 | $0.68 | $13,578.00 |
DisclosureSEC source: 0001437749-24-020694 · rdgdoc.xml · nonDerivative · entry 1 Watson W. Mark · CIK 0001612372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,125 Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 20:36 UTC |
Lee Phillip EChief Financial Officer
|
Tax withholdingCommon Stock | 2,007 | $0.76 | $1,525.32 |
DisclosureSEC source: 0001437749-24-020205 · rdgdoc.xml · nonDerivative · entry 1 Lee Phillip E · CIK 0001959565 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239,801 F1 · shares: Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of June 12, 2024. Read SEC document |
| June 11, 2024 Filed Jun 12, 2024 20:40 UTC |
Wheadon David E.Director
|
GrantStock Option (right to buy) · Derivative | 95,400 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001437749-24-020098 · rdgdoc.xml · derivative · entry 2 Wheadon David E. · CIK 0001789507 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,400 Underlying: Common Stock · 95,400 shares Expires 2034-06-11 F2 · derivative.exercise_date: The shares subject to this option shall vest on the earlier of the date immediately prior of the 2025 annual meeting of stockholders of the Issuer and June 11, 2025, the first anniversary of the date of the grant. Read SEC document |
| June 11, 2024 Filed Jun 12, 2024 20:40 UTC |
Wheadon David E.Director
|
GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-020098 · rdgdoc.xml · nonDerivative · entry 1 Wheadon David E. · CIK 0001789507 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,750 F1 · shares: Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2025 annual meeting of stockholders of the Issuer and June 11, 2025, the first anniversary date of the grant. Read SEC document |
| June 11, 2024 Filed Jun 12, 2024 20:40 UTC |
Finney Michael J.Director
|
GrantStock Option (right to buy) · Derivative | 95,400 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001437749-24-020097 · rdgdoc.xml · derivative · entry 2 Finney Michael J. · CIK 0001650978 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,400 Underlying: Common Stock · 95,400 shares Expires 2034-06-11 F2 · derivative.exercise_date: The shares subject to this option shall vest on the earlier of the date immediately prior of the 2025 annual meeting of stockholders of the Issuer and June 11, 2025, the first anniversary of the date of the grant. Read SEC document |
| June 11, 2024 Filed Jun 12, 2024 20:40 UTC |
Finney Michael J.Director
|
GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-020097 · rdgdoc.xml · nonDerivative · entry 1 Finney Michael J. · CIK 0001650978 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 686,840 F1 · shares: Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2025 annual meeting of stockholders of the Issuer and June 11, 2025, the first anniversary date of the grant. Read SEC document |
| June 11, 2024 Filed Jun 12, 2024 20:39 UTC |
HERON ELAINE JDirector
|
GrantStock Option (right to buy) · Derivative | 95,400 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001437749-24-020096 · rdgdoc.xml · derivative · entry 2 HERON ELAINE J · CIK 0001235471 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,400 Underlying: Common Stock · 95,400 shares Expires 2034-06-11 F2 · derivative.exercise_date: The shares subject to this option shall vest on the earlier of the date immediately prior of the 2025 annual meeting of stockholders of the Issuer and June 11, 2025, the first anniversary of the date of the grant. Read SEC document |
| June 11, 2024 Filed Jun 12, 2024 20:39 UTC |
HERON ELAINE JDirector
|
GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-020096 · rdgdoc.xml · nonDerivative · entry 1 HERON ELAINE J · CIK 0001235471 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,566 F1 · shares: Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2025 annual meeting of stockholders of the Issuer and June 11, 2025, the first anniversary date of the grant. Read SEC document |
| June 11, 2024 Filed Jun 12, 2024 20:39 UTC |
Watson W. MarkDirector
|
GrantStock Option (right to buy) · Derivative | 95,400 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001437749-24-020095 · rdgdoc.xml · derivative · entry 2 Watson W. Mark · CIK 0001612372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,400 Underlying: Common Stock · 95,400 shares Expires 2034-06-11 F2 · derivative.exercise_date: The shares subject to this option shall vest on the earlier of the date immediately prior of the 2025 annual meeting of stockholders of the Issuer and June 11, 2025, the first anniversary of the date of the grant. Read SEC document |
| June 11, 2024 Filed Jun 12, 2024 20:39 UTC |
Watson W. MarkDirector
|
GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-020095 · rdgdoc.xml · nonDerivative · entry 1 Watson W. Mark · CIK 0001612372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,125 F1 · shares: Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2025 annual meeting of stockholders of the Issuer and June 11, 2025, the first anniversary date of the grant. Read SEC document |
| June 11, 2024 Filed Jun 12, 2024 20:38 UTC |
Yedid Robert A.Director
|
GrantStock Option (right to buy) · Derivative | 95,400 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001437749-24-020094 · rdgdoc.xml · derivative · entry 2 Yedid Robert A. · CIK 0001792558 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,400 Underlying: Common Stock · 95,400 shares Expires 2034-06-11 F2 · derivative.exercise_date: Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2025 annual meeting of stockholders of the Issuer and June 11, 2025, the first anniversary date of the grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.